Aidea Pharmaceutical announced that the listed company plans to purchase 31.161% equity of Nanjing Pharmaceutical held by Huaxi Yin Feng, Hunan Kecheng, Xu Zhihuai, Chen Lei, and Yao Fandi for a transaction price of 149,572.8 million yuan in cash.
艾迪药业：公司拟通过支付现金购买南大药业31.161%的股权
Aidea Pharmaceutical: The company plans to purchase 31.161% equity of Nanjing Pharmaceutical with cash
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.